PD-L1 expression in sarcoma is varied, and the data regarding the correlation between PD-L1 expression and responsiveness to ICI in STS is variable, and at this time there is not a consistent correlation[5,29,30]. This evidence concerns the gene CD274 and telomere syndrome.